The global assisted
reproductive technology market is expected to reach USD 29.3 billion by 2022,
according to a new report by Grand View Research Inc. Growing prevalence of
stress and increase in the pollution levels coupled with the changing lifestyle
habits including smoking and drinking are expected to drive the assisted
reproductive technology market over the forecast period.
Growing incidence rate of male
and female infertility due to low sperm count, poor sperm movement, blocked
sperm ducts, and fallopian tubes blockage coupled with problems in uterus or
cervix, respectively is expected to significantly contribute towards market
growth.
In depth research report on Assisted Reproductive
Technology (ART) Market
Medical tourism is instrumental
in facilitating growing demand of assisted human reproductive technology.
Although, these technologies are widely used in the developed economies of the
U.S. and Canada, entailed high costs render these services unavailable to every
patient. Nations are regulated by stringent laws and govern the transactions
between surrogates, egg donors, and those who are willing to avail these
services.
Countries such as Czech
Republic, Israel, South Africa, and Spain offer good fertility options. India
and Mexico were among the most technologically and economically viable
fertility choices for foreign couples. Success rates as good as other western
nations and with less than half the cost, are few factors spearheading regional
growth.
Further key findings from the report suggest:
·
Fresh non-donor was the largest
ART market procedure segment in 2014. The fact that fresh eggs and sperms
increase the number of successful pregnancies is expected to drive segment
growth over the forecast period.
·
Frozen non-donor is identified
as the most lucrative segment of assisted reproductive technology industry. It
is expected to grow at a CAGR of over 5.5% over the forecast period.
·
North America dominated global
demand accounting for USD 8.5 billion in 2014. This is attributed to rising
people awareness and acceptance of people towards gametes preservation and
donation, government funding for in vitro fertilization, and high usage rate of
advanced technologies such as vitrification.
·
Asia Pacific is expected to
witness substantial growth over the forecast period owing to increasing
prevalence of obesity and average maternal age in the emerging markets of India
and China.
·
The Asia Pacific Initiative on
Reproduction (ASPIRE) task force of clinicians and scientists are involved in
the monitoring and management of fertility and Assisted Reproductive Technology
(ART).
·
Key players of the assisted
reproductive technology market include Cosmos Biomedical, Origio, European
Sperm Bank, Cryolab Ltd., Ovascience, Parallabs, Microm UK Ltd., Irvine
Scientific, and Bloom IVF Centre.
Grand View Research has
segmented the assisted reproductive technology market on the basis of the procedure
and region:
Procedure Outlook (Revenue, USD Million, 2012 - 2022)
·
Fresh Donor
·
Fresh Non-donor
·
Frozen Donor
·
Frozen Non-donor
·
Embryo/Egg Banking
Regional Outlook (Revenue, USD Million, 2012 - 2022)
·
North America
·
U.S.
·
Canada
·
Europe
·
UK
·
Germany
·
France
·
Italy
·
Spain
·
Asia Pacific
·
Japan
·
China
·
India
·
Latin America
·
Brazil
·
Mexico
·
Middle East and Africa
·
South Africa
Browse more research reports of this category:
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
No comments:
Post a Comment